tiprankstipranks
Trending News
More News >
Ecolab Inc (ECL)
NYSE:ECL
Advertisement

Ecolab (ECL) AI Stock Analysis

Compare
1,420 Followers

Top Page

ECL

Ecolab

(NYSE:ECL)

Rating:80Outperform
Price Target:
$321.00
â–²(17.48% Upside)
Ecolab's overall stock score of 80 reflects its strong financial performance and positive earnings call sentiment, which are the most significant factors. The technical analysis supports a bullish trend, while the valuation indicates a premium price, suggesting high market expectations. The company's strategic focus on high-margin growth businesses and effective cost management further bolster its outlook, despite some challenges in specific segments.
Positive Factors
Acquisitions
Ecolab's acquisition of Ovivo Electronics is set to more than double the size of its existing global high-tech water business.
Earnings Growth
ECL is expected to continue to post double-digit EPS growth from 2025 to 2027, supported by solid pricing and share gains.
Financial Performance
Ecolab's strong margin improvement is driving the company's best return on invested capital (ROIC) in nearly a decade.
Negative Factors
Pricing Concerns
Pricing during the quarter disappointed investors, up 2% in line with 1Q levels despite the tariff surcharge in the U.S. being announced.
Stock Performance
The stock's performance has lagged the broader materials space, and expectations of a modest beat were not met.

Ecolab (ECL) vs. SPDR S&P 500 ETF (SPY)

Ecolab Business Overview & Revenue Model

Company DescriptionEcolab Inc. is a global leader in water, hygiene, and energy technologies and services. The company operates through various sectors, primarily focusing on institutional, industrial, and commercial markets. Ecolab provides a range of products and services, including cleaning and sanitization solutions, water treatment, pest control, and food safety services, aiming to enhance operational efficiency and sustainability for its customers.
How the Company Makes MoneyEcolab generates revenue through multiple streams, primarily by offering a wide array of products and services tailored to various industries, including food and beverage, healthcare, hospitality, and manufacturing. The company's revenue model consists of direct sales of chemical products and equipment, as well as recurring revenue from service contracts and maintenance agreements. Significant partnerships with large corporations and government entities further enhance its earnings potential. Ecolab also invests in innovation and technology to develop new solutions that meet evolving customer needs, thereby driving growth through improved customer retention and expanded market reach.

Ecolab Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Breaks down sales across various business areas, indicating which segments are performing well and contributing most to overall revenue growth.
Chart InsightsEcolab's Industrial and Institutional segments show robust growth, with the Industrial segment consistently expanding and reaching new highs by the end of 2024. However, the Healthcare and Lifesciences segment faces volatility, with a notable decline in late 2024. The 'Other' and 'Corporate' segments have ceased contributing to revenue in 2025, indicating possible strategic shifts or divestitures. This restructuring could signal a focus on core growth areas, but the absence of earnings call commentary leaves potential risks and strategic intentions unclear.
Data provided by:Main Street Data

Ecolab Earnings Call Summary

Earnings Call Date:Jul 29, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 04, 2025
Earnings Call Sentiment Positive
Ecolab's earnings call reflected a generally positive sentiment, with strong earnings growth, resilient core business performance, and advancements in digital and high-tech segments. However, challenges remain in certain segments like basic industries and paper, as well as ongoing commodity cost pressures. Overall, the positives in growth and strategic execution outweighed the areas of concern.
Q2-2025 Updates
Positive Updates
Strong Earnings Growth
Ecolab reported double-digit earnings growth, achieving a 13% increase in earnings for the second quarter, in line with expectations and guidance.
Resilient Business Portfolio
85% of Ecolab's business grew organic sales by 4% and operating income by 18%, demonstrating the strength and resilience of its business portfolio.
Growth in Core Segments
Global Water sales growth accelerated to 4%, and operating income grew double digits, led by food and beverage and strong execution of the One Ecolab growth strategy.
Pest Elimination and Digital Advancements
Pest Elimination's organic sales growth accelerated to 6%, driven by the shift to a digital pest intelligence model, with operating income margins increasing to nearly 20%.
Strong Balance Sheet and Cash Flow
Ecolab maintains a strong balance sheet with a low leverage ratio of 1.7, positioning the company for organic and inorganic growth opportunities.
Life Sciences and Global High-Tech Growth
Life Sciences grew mid-single digits, with strong double-digit growth in biopharma, and Global High-Tech business sales were up over 30%.
Negative Updates
Challenges in Basic Industries and Paper Business
End market demand remained uneven, particularly in the paper and basic industries businesses, which represent 15% of Ecolab's total sales.
Commodity Cost Increases
Commodity costs are anticipated to keep increasing by low to mid-single digits in the second half of the year and in 2026.
Pricing Pressure
Pricing in the Water division was lower than expected, with a need to improve pricing in the second half, particularly in basic and paper industries.
Company Guidance
During Ecolab's second quarter 2025 earnings call, the company reported strong financial performance consistent with its guidance. It achieved a 3% growth in organic sales, driven by a robust 4% growth in 85% of its business, while operating income grew by 18%. Key growth drivers included a 2% increase in value pricing, which is anticipated to rise closer to 3% in subsequent quarters due to a new trade surcharge for U.S. customers. The Institutional & Specialty segment, along with Global Water, performed well, with the latter seeing 4% sales growth excluding paper and basic industries, which faced challenges. The Pest Elimination business showed a 6% organic sales increase, with operating income margins nearing 20%. Ecolab's growth engines, including Pest Elimination, Life Sciences, Global High-Tech, and Ecolab Digital, collectively grew double digits, contributing to a 170 basis points rise in operating income margin. Despite anticipated commodity cost increases, Ecolab expects its full-year 2025 operating income margin to reach 18%, with an aim for a 20% margin by 2027, supported by continued investment in high-margin growth businesses.

Ecolab Financial Statement Overview

Summary
Ecolab demonstrates strong financial performance with consistent revenue growth and robust profitability margins. The balance sheet reflects a stable capital structure with manageable leverage, while the cash flow position underscores efficient cash generation capabilities. Potential risks include the high debt level, but the company's growth trajectory and profitability trends are promising.
Income Statement
85
Very Positive
Ecolab's income statement reflects strong profitability with a consistent increase in gross profit margin from 41.4% in 2020 to 43.7% in TTM 2025. The net profit margin has also improved, reaching 13.4% in TTM 2025, indicating efficient cost management. Revenue growth has been steady, with a notable 21.0% increase from 2020 to 2021 and continued growth across subsequent years, though slightly declining in TTM 2025. EBIT and EBITDA margins have shown robust performance, reflecting operational efficiency. Overall, Ecolab demonstrates solid revenue growth and profitability metrics.
Balance Sheet
78
Positive
Ecolab's balance sheet shows a stable financial position with a debt-to-equity ratio of 0.93 in TTM 2025, highlighting moderate leverage. The return on equity has improved from 15.9% in 2020 to 23.7% in TTM 2025, indicating effective use of shareholder equity. The equity ratio remains reasonable at 39.7%, suggesting a balanced capital structure. However, the company's total debt level, while stable, remains significant, which could pose a risk in adverse economic conditions.
Cash Flow
82
Very Positive
Ecolab's cash flow statement reveals a healthy free cash flow generation, with a growth rate of 27.5% from 2022 to TTM 2025. The operating cash flow to net income ratio is strong at 1.03 in TTM 2025, indicating solid cash generation relative to net income. However, the decline in free cash flow from 2024 to TTM 2025 suggests potential volatility in cash flow despite overall positive performance. The company maintains a focus on capital investments, supporting future growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.68B15.74B15.32B14.19B12.73B11.79B
Gross Profit6.86B6.84B6.18B5.42B5.22B4.90B
EBITDA3.88B3.85B3.03B2.55B2.47B2.22B
Net Income2.10B2.11B1.37B1.09B1.13B-1.21B
Balance Sheet
Total Assets22.37B22.39B21.85B21.46B21.21B18.13B
Cash, Cash Equivalents and Short-Term Investments1.16B1.26B919.50M598.60M359.90M1.26B
Total Debt8.36B8.28B8.73B9.03B9.16B7.11B
Total Liabilities13.46B13.60B13.77B14.21B13.95B11.92B
Stockholders Equity8.88B8.76B8.04B7.24B7.22B6.17B
Cash Flow
Free Cash Flow1.50B1.82B1.64B1.08B1.42B1.37B
Operating Cash Flow2.53B2.81B2.41B1.79B2.06B1.86B
Investing Cash Flow-456.80M-433.80M-990.50M-716.80M-4.58B-414.50M
Financing Cash Flow-1.38B-2.02B-1.05B-837.30M1.60B-341.80M

Ecolab Technical Analysis

Technical Analysis Sentiment
Positive
Last Price273.23
Price Trends
50DMA
271.98
Positive
100DMA
263.42
Positive
200DMA
255.41
Positive
Market Momentum
MACD
1.45
Positive
RSI
48.87
Neutral
STOCH
12.10
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ECL, the sentiment is Positive. The current price of 273.23 is below the 20-day moving average (MA) of 278.42, above the 50-day MA of 271.98, and above the 200-day MA of 255.41, indicating a neutral trend. The MACD of 1.45 indicates Positive momentum. The RSI at 48.87 is Neutral, neither overbought nor oversold. The STOCH value of 12.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ECL.

Ecolab Risk Analysis

Ecolab disclosed 23 risk factors in its most recent earnings report. Ecolab reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ecolab Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$77.94B36.7524.26%0.92%0.57%25.50%
79
Outperform
$23.84B36.699.73%0.97%2.47%63.68%
78
Outperform
$15.76B22.9525.42%1.63%0.51%17.21%
68
Neutral
$65.03B42.0010.26%2.44%-0.38%-39.53%
67
Neutral
$31.73B40.240.31%2.13%4.55%-130.25%
64
Neutral
$24.73B19.4316.88%2.51%-10.59%-7.79%
61
Neutral
$10.27B6.370.76%2.91%3.10%-36.03%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ECL
Ecolab
274.94
30.67
12.56%
APD
Air Products and Chemicals
289.97
23.05
8.64%
PPG
PPG Industries
109.64
-12.66
-10.35%
RPM
RPM International
125.11
13.02
11.62%
STE
Steris
243.39
6.76
2.86%
DD
DuPont de Nemours
77.15
-2.55
-3.20%

Ecolab Corporate Events

Private Placements and FinancingM&A Transactions
Ecolab Completes $500 Million Notes Issuance
Neutral
Aug 27, 2025

On August 27, 2025, Ecolab Inc. completed the issuance of $500 million in 5.000% Notes due 2035, following an underwriting agreement with major financial institutions. The proceeds from this offering are intended for general corporate purposes, including funding a previously announced acquisition and debt repayment, potentially impacting the company’s financial flexibility and strategic positioning.

Executive/Board Changes
Ecolab Appoints Julie P. Whalen to Board
Positive
Aug 6, 2025

On August 6, 2025, Ecolab Inc. announced the appointment of Julie P. Whalen to its Board of Directors, where she will also serve on the Audit and Finance Committees. Ms. Whalen brings extensive experience from her previous roles as CFO at Expedia Group and Williams-Sonoma, enhancing Ecolab’s finance and audit capabilities. Her appointment is expected to strengthen Ecolab’s strategic planning and governance, contributing to the company’s ongoing success and shareholder returns.

Executive/Board Changes
Ecolab Announces Executive Vice President’s Resignation
Neutral
Jul 18, 2025

On July 14, 2025, Machiel Duijser resigned from his role as Executive Vice President and Chief Supply Chain Officer at Ecolab Inc., effective July 25, 2025, to join another publicly traded company. Ecolab has a succession plan in place and will appoint an internal successor, with Duijser’s departure not stemming from any disagreements with the company’s operations or policies.

Private Placements and Financing
Ecolab Completes $500 Million Notes Issuance
Neutral
Jun 5, 2025

On June 5, 2025, Ecolab Inc. completed the issuance of $500 million in 4.300% Notes due 2028, following an underwriting agreement with Barclays Capital Inc., BofA Securities, Inc., and Santander US Capital Markets LLC. The proceeds from these Notes, which are part of a series of debt securities, are intended for general corporate purposes, potentially including debt repayment. The Notes, which bear interest payable semi-annually, are subject to redemption and repurchase conditions under certain circumstances, and the issuance is governed by covenants limiting certain financial activities.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2025